Etoposide Injection, Solution, Concentrate
Product Images NDC 68001-682

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 68001-682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Etoposide 100mg/5ml Carton (Etoposide 100mg Carton)

Packaging label for Etoposide Injection USP, 20 mg/mL (100 mg per 5 mL) concentrate for intravenous injection, manufactured by BluePoint Laboratories. Label includes dosage form, strength, usage warning for cytotoxic agent, storage instructions, and manufacturer details. Product is in multiple-dose 5 mL vial format.*

FDA Label Image

Etoposide 100mg/5ml Label (Etoposide 100mg Vial)

Label for Etoposide Injection, USP 100 mg per 5 mL (20 mg per mL) intravenous solution, multiple-dose vial. The label includes dilution instructions, container volume (5 mL), and ingredients. It is manufactured by Kindos Pharmaceuticals Co., Ltd., distributed by BluePoint Laboratories, and denotes storage instructions and handling cautions.*

FDA Label Image

Etoposide 1gm/50ml Label (Etoposide 1g Carton)

Label for Etoposide Injection, USP 1 gram per 50 mL (20 mg per mL) concentrate for intravenous injection. The product is labeled as cytotoxic and requires dilution before use. It is supplied by BluePoint Laboratories in multiple-dose vials. The label includes storage instructions, ingredient details, and manufacturer information, including that it is made in Italy.*

FDA Label Image

Etoposide 1gm/50ml Label (Etoposide 1g Vial)

Etoposide Injection, USP 20 mg/mL solution in a 50 mL multiple-dose vial label. The label states '1 gram per 50 mL' and includes dilution instructions for intravenous infusion. It lists the active ingredient etoposide and excipients, storage conditions, and notes that the container is non-reactive and latex-free. The label is from BluePoint Laboratories and includes NDC 68001-683-27.*

FDA Label Image

Etoposide 500mg/25ml Carton (Etoposide 500mg Carton)

Packaging label for Etoposide Injection, USP 500 mg per 25 mL (20 mg/mL) concentrate solution for intravenous injection. The label indicates the product is a cytotoxic agent requiring dilution before infusion. It shows NDC 68001-682-26, BluePoint Laboratories branding, and includes storage and handling information. The label is designed for a 25 mL multiple-dose vial.*

FDA Label Image

Etoposide 500mg/20ml Label (Etoposide 500mg Vial)

Etoposide Injection, USP 20 mg/mL (500 mg per 25 mL) concentrate for intravenous use in a multiple-dose vial. Label includes dilution instructions and details preservative status, storage conditions, and manufacturer BluePoint Laboratories with product origin from Italy.*

FDA Label Image

Structural Formula (Etoposide Structure)

Chemical structure of Etoposide, showing the molecular formula C29H32O13 and molecular weight 588.56. The diagram details the arrangement of atoms and bonds within the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.